ENANTA PHARMACEUTICALS, INC (ENTA) Free cash flow 2017–2025
ENANTA PHARMACEUTICALS, INC (ENTA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$32.2MFY2025 · since FY2017: $50.1M → -$32.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$32.2M | +66.7% |
| FY2024 | -$96.7M | +13.8% |
| FY2023 | -$112.2M | -29.1% |
| FY2022 | -$86.9M | -22.8% |
| FY2021 | -$70.7M | -1353.7% |
| FY2020 | $5.6M | -91.5% |
| FY2019 | $66.0M | +151.5% |
| FY2018 | $26.2M | -47.7% |
| FY2017 | $50.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice